LGOQX
Price
$23.60
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
PMAQX
Price
$48.46
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

LGOQX vs PMAQX

Header iconLGOQX vs PMAQX Comparison
Open Charts LGOQX vs PMAQXBanner chart's image
Lord Abbett Growth Opportunities R2
Price$23.60
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Principal MidCap R6
Price$48.46
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
LGOQX vs PMAQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LGOQX vs. PMAQX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGOQX is a Buy and PMAQX is a Buy.

FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 29.8B vs. LGOQX (542M). PMAQX pays higher dividends than LGOQX: PMAQX (0.10) vs LGOQX (0.00). LGOQX was incepted earlier than PMAQX: LGOQX (17 years) vs PMAQX (8 years). LGOQX is a more actively managed with annual turnover of: 149.00 vs. PMAQX (10.10). LGOQX (0) and PMAQX (0) have matching initial minimum investment requirements. LGOQX annual gain was more profitable for investors over the last year : 44.79 vs. PMAQX (32.12). PMAQX return over 5 years is better than : 55.10 vs. LGOQX (1.51).
LGOQXPMAQXLGOQX / PMAQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years8 years-
Gain YTD34.78026.395132%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets542M29.8B2%
Annual Yield % from dividends0.000.10-
Returns for 1 year44.7932.12139%
Returns for 3 years-23.136.88-336%
Returns for 5 years1.5155.103%
Returns for 10 years3.42N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LIXT1.65-0.03
-1.79%
Lixte Biotechnology Holdings
ATRO16.49-0.38
-2.25%
Astronics Corp
LFST7.22-0.18
-2.43%
LifeStance Health Group
CVNA239.98-6.77
-2.74%
Carvana Co
IPSC1.33-0.08
-5.67%
Century Therapeutics